Axiron ES 1000 mg/500 mg Injection
By Axiron ES
Rx
1 Injection in a Vial

Composition
Ceftriaxone(1000mg) + Sulbactam(500mg)

Manufacturer - Bsp Pharmaceuticals
Via Appia Km. 65,561, 04013 Latina Scalo (LT), Italy

Expires on or after
July, 2025

liver
When using Axiron ES 1000 mg/500 mg Injection, it is important to be cautious if you have severe liver disease. In such cases, a dose adjustment may be necessary, and it is advisable to consult your doctor. However, for individuals with mild to moderate liver disease, dose adjustment of Axiron ES 1000 mg/500 mg Injection is generally not recommended. It's crucial to consider your liver health when using this medication to ensure its safety and effectiveness.

kidney
Limited information exists on using Axiron ES 1000 mg/500 mg Injection in patients with kidney disease. Kindly seek advice from your doctor for guidance.

alcohol
It is safe to consume alcohol with Axiron ES 1000 mg/500 mg Injection with no harmful side effects.

driving
Axiron ES 1000 mg/500 mg Injection can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these side effects.

pregnancy
Axiron ES 1000 mg/500 mg Injection is generally considered safe to use during pregnancy based on animal studies showing low risk to the developing baby. Limited human studies are available.

breastfeeding
Axiron ES 1000 mg/500 mg Injection needs caution while breastfeeding. It's advisable to pause breastfeeding until the mother's treatment is done and the drug is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹122
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024